Jeremy Clarkson recently disclosed that he has been diagnosed with aggressive prostate cancer, sharing the news during the fifth season of his series, Clarkson’s Farm. While the diagnosis was serious, the cancer was detected early. Clarkson explained to farm manager Kaleb Cooper and land agent Charlie Ireland that he had undergone surgery to remove part of his prostate, and he would only know if the operation was successful several months later.
Clarkson’s candid revelation highlights an important aspect of prostate cancer treatment — not all men choose immediate intervention. According to cancer researcher Luisel Ricks-Santi, Associate Professor of Pharmacy at the University of Florida, many men diagnosed with low-risk or intermediate-risk prostate cancer opt for active surveillance instead of surgery or radiation.
“Prostate cancer can be grouped into four stages,” Ricks-Santi explains. “Stages 1 and 2 are early-stage or intermediate risk, where the tumor is still confined to the prostate. Stages 3 and 4 indicate more advanced cancer that has spread beyond the prostate.” Treatment approaches vary by stage: early-stage patients may receive surgery, radiation, or brachytherapy, while those with advanced cancer might undergo hormone therapy, chemotherapy, or a combination of treatments.
READ MORE: Around 200 Lives Saved by HPV Vaccine in England
READ MORE: ‘I called Kate Middleton when she was in depths of despair - she showed her true colours’
However, Ricks-Santi points out that about 60% of men with low-risk, slow-growing prostate cancer choose no immediate treatment, and 12% to 22% of men with intermediate-risk disease follow this approach. This choice stems from the nature of many prostate tumors, which tend to grow so slowly that they do not pose a significant threat during a patient’s lifetime.
“This situation leads to overdiagnosis,” Ricks-Santi says, “meaning many prostate cancers discovered through PSA testing would never harm the patient if left untreated.” Overdiagnosis can result in overtreatment, which carries risks such as urinary and bowel incontinence, sexual dysfunction, and even serious complications.
Research indicates that men with early-stage prostate cancer have an excellent prognosis, with the disease rarely advancing rapidly. Through careful observation and regular monitoring, most men avoid unnecessary treatments and their potential side effects, proceeding with intervention only if there are clear signs that the cancer is progressing.
This approach underscores the importance of personalized treatment plans and informed decision-making for prostate cancer patients, balancing effective care with quality of life considerations.